Biased News

The rise of China’s biotech industry
english.ckgsb.edu.cn ‧ Verbal Cooperation ‧ Neutral tone ‧ diplomatic cooperation ‧ Moderate Impact ‧ 4 days ago
How EPS Corporation Is Advancing Clinical Development Across Japan and Asia
www.theworldfolio.com ‧ Verbal Cooperation ‧ Positive tone ‧ express intent to cooperate ‧ High Impact ‧ 4 days ago
Kane Engages Independent Trading Group as Market Maker
www.theobserver.ca ‧ Verbal Cooperation ‧ Neutral tone ‧ express intent to cooperate ‧ High Impact ‧ 10 days ago
FIERCE BIOTECH NAMES REPRONOVO A "FIERCE 15” BIOTECH COMPANY OF 2026
www.manilatimes.net ‧ Material Cooperation ‧ Neutral tone ‧ material cooperation ‧ High Impact ‧ 27 days ago
Kane Engages Independent Trading Group as Market Maker
www.manilatimes.net ‧ Verbal Conflict ‧ Neutral tone ‧ threaten ‧ Moderate Impact ‧ 10 days ago
Speed up EU health security prep, says NATO chief medic
www.politico.eu ‧ Verbal Cooperation ‧ Neutral tone ‧ public statement ‧ Moderate Impact ‧ 30 days ago
Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026
www.simcoereformer.ca ‧ Verbal Conflict ‧ Neutral tone ‧ threaten ‧ Moderate Impact ‧ 25 days ago
Phase 1, 2, And 3 Clinical Trials Explained: What Every Biotech Investor Needs To Know
www.rttnews.com ‧ Material Cooperation ‧ Neutral tone ‧ provide aid ‧ Moderate Impact ‧ 25 days ago
In Shanghai’s ‘Science City,’ China’s ascendant biotechs make their pitch to the world
www.bostonglobe.com ‧ Verbal Cooperation ‧ Neutral tone ‧ consult ‧ Moderate Impact ‧ 26 days ago
Kane Biotech Signs Distribution Agreement with The Stevens Company
www.manilatimes.net ‧ Material Cooperation ‧ Neutral tone ‧ provide aid ‧ High Impact ‧ 12 days ago
Euro Roundup: European Commission calls for EMA to urgently advance Biotech Act preparations
www.raps.org ‧ Verbal Cooperation ‧ Neutral tone ‧ appeal ‧ Moderate Impact ‧ 23 days ago
Freya Biosciences named as one of Fierce Biotech’s "Fierce 15” for 2026
www.manilatimes.net ‧ Verbal Cooperation ‧ Neutral tone ‧ diplomatic cooperation ‧ High Impact ‧ 27 days ago
Philadelphia discovers. Boston profits. That can change.
americanbazaaronline.com ‧ Material Cooperation ‧ Neutral tone ‧ material cooperation ‧ High Impact ‧ 20 days ago
Oncolytics Biotech (TSE:ONC) Stock Crosses Above 200 Day Moving Average – Should You Sell?
www.tickerreport.com ‧ Verbal Cooperation ‧ Neutral tone ‧ public statement ‧ Moderate Impact ‧ 8 days ago
Kane to Showcase revyve® at Wounds Canada National Hybrid Conference
www.standard-freeholder.com ‧ Verbal Conflict ‧ Neutral tone ‧ threaten ‧ Moderate Impact ‧ 12 days ago
Kane Launches New Corporate Brand and Redesigned Website
www.manilatimes.net ‧ Verbal Conflict ‧ Neutral tone ‧ threaten ‧ Moderate Impact ‧ 13 days ago
Kane Launches New Corporate Brand and Redesigned Website
www.nugget.ca ‧ Verbal Cooperation ‧ Neutral tone ‧ public statement ‧ Moderate Impact ‧ 13 days ago
Introducing Lab Rats: A Mint series on India’s biotech startups
www.livemint.com ‧ Verbal Conflict ‧ Neutral tone ‧ protest ‧ Moderate Impact ‧ 6 days ago
Big Pharma’s China deals worth billions: Chinese biotech out licensing deals to surpass $250 billion in 2026
yalibnan.com ‧ Verbal Cooperation ‧ Neutral tone ‧ diplomatic cooperation ‧ High Impact ‧ 29 days ago
ISAAA, Inc. and DA-BPO Release Fifth Issue of Pinoy Biotek Magazine
www.isaaa.org ‧ Verbal Cooperation ‧ Positive tone ‧ public statement ‧ Moderate Impact ‧ 4 days ago
The 6th BioCentury-BayHelix East-West Biopharma Summit Returns to Seoul Amid Unprecedented Demand for Cross-Border Deals
www.simcoereformer.ca ‧ Material Conflict ‧ Positive tone ‧ assault ‧ Moderate Impact ‧ 3 days ago
The C-suite agenda: Capital, partnering, and AI take center stage for biopharma leaders
www.bioxconomy.com ‧ Verbal Conflict ‧ Neutral tone ‧ demand ‧ Moderate Impact ‧ 19 days ago
Octane Biotech and Currus Biologics Automate Manufacturing of CUR-001 CAR T-Cell Therapy on the Cocoon® Platform
www.manilatimes.net ‧ Material Conflict ‧ Neutral tone ‧ fight ‧ Moderate Impact ‧ 5 days ago
Europe’s Opportunity To Capture The Value In China Biotech, Investors In Healthcare
www.mondaq.com ‧ Verbal Cooperation ‧ Positive tone ‧ consult ‧ Moderate Impact ‧ 20 days ago
Avance Clinical to Meet European Biotechs at ESMO Congress 2026 and Appoints Wendy Hamon as Senior Vice President, Oncol...
www.finanznachrichten.de ‧ Verbal Cooperation ‧ Neutral tone ‧ express intent to cooperate ‧ Moderate Impact ‧ 11 days ago